AZUL SA director David Neeleman acquires 585K shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AZUL SA director David Neeleman acquired 584,783 Anti-Dilution Grant Restricted Shares on November 9, 2026, under anti-dilution protection for previously granted restricted shares. The shares vested automatically on the grant date, and AZUL SA issued them after he paid an aggregate nominal subscription price of R$1.00 (approximately US$0.20). His reported direct holdings following the transaction were 4,349,029 shares; the balance of his previously reported Restricted Shares remains subject to time-based vesting.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares F1, F2 | 584,783 | $0.00 | $0.00 |
Footnotes (2)
- F1. Represents 584,783 rights to acquire common shares of Azul S.A. (the "Anti-Dilution Grant Restricted Shares") granted pursuant to the anti-dilution protection provided to the restricted shares previously granted to the Reporting Person and reported on a Form 4 filed by the Reporting Person on March 30, 2026 (the "Restricted Shares") under Section 6.2 of the Restricted Shares Granting Plan of Azul S.A. and applicable documentation thereunder ("Plan"). The 584,783 Anti-Dilution Grant Restricted Shares vested automatically on the grant date of November 9, 2026.
- F2. On November 9, 2026, in accordance with the terms of the Plan and the relevant program and grant agreement thereunder, the Reporting Person paid an aggregate nominal subscription price of R$ 1.00 (one Brazilian real), which is equivalent to approximately US$ 0.20 (twenty cents) and Azul S.A. issued to the Reporting Person the 584,783 Anti-Dilution Grant Restricted Shares referred to above. The balance of the Restricted Shares reported as beneficially owned remain subject to time-based vesting, as previously reported.
Key Figures
Key Terms
time-based vesting technical
nominal subscription price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.